Advanced Lyophilization Solutions for Biotech and Pharmaceutical Industry
At LYOMAC, we specialize in providing cutting-edge freeze-drying solutions tailored to the rigorous demands of new formulation. Our extensive range of lyophilizers is engineered to support the production of today's most critical therapies, including anti-cancer drugs (oncology), vaccines, and API intermediates. Whether you are in the R&D phase or scaling up for mass production, LYOMAC offers the precision and reliability your process requires.
Choose the Lyophilizer for Your Product
- Lab scale lyophilizer — Drying capacity: 2~12 Liters
- Pilot scale Lyophilizer — Drying capacity: 20~60 Liters
- Industrial/massive Lyophilizer — Drying capacity: 100~1,000 Liters
- API Lyophilization with Dosing system — Drying capacity: 10~1,000 Liters
- Auto loading system for vial formulation — Row by row system
Key Compliance & Features
- ✓ GMP/FDA compliance
- ✓ 21CFR control SCADA system
- ✓ Auto CIP, SIP, Stoppering, Auto loading
17 Years of Lyophilization Expertise & Professionalism
LYOMAC freeze dryers are essential for ensuring the stability, purity, and activity of pharmaceutical raw materials. Especially for sensitive APIs like peptides, mRNA components, and sterile intermediates, our advanced technology offers precise process control, aseptic processing capabilities, and full regulatory compliance (cGMP, FDA). Trust LYOMAC for robust, scalable solutions that safeguard the integrity of your most critical pharmaceutical ingredients.